TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
WP2853	Endoderm Differentiation	0.0161644624161736	-4.12494012439401	145	3	0.15	20	5311	79776,5083,23007	ZFHX4,PAX9,PLCH1
WP2485	NAD Biosynthesis II (from tryptophan)	0.0297514153030612	-3.51487857490993	8	1	0.05	20	5311	8942	KYNU
WP3593	miR-148a/miR-31/FIH1/HIF1&alpha;-Notch signaling in glioblastoma	0.0334106594463373	-3.39888028481553	9	1	0.05	20	5311	23462	HEY1
WP15	Selenium Micronutrient Network	0.04163826659946	-3.17873566435689	87	2	0.1	20	5311	6289,8942	SAA2,KYNU
WP1425	Bone Morphogenic Protein (BMP) Signalling and Regulation	0.0443098912615971	-3.11654734781128	12	1	0.05	20	5311	658	BMPR1B
WP615	Senescence and Autophagy in Cancer	0.0593704631819759	-2.82395842911341	106	2	0.1	20	5311	1029,9547	CDKN2A,CXCL14
WP1742	TP53 Network	0.0728066061499265	-2.6199485840788	20	1	0.05	20	5311	1029	CDKN2A
WP205	IL-7 Signaling Pathway	0.0902051254494604	-2.40566903036318	25	1	0.05	20	5311	3574	IL7
WP2895	Differentiation of white and brown adipocyte	0.0902051254494604	-2.40566903036318	25	1	0.05	20	5311	7545	ZIC1
WP530	Cytokines and Inflammatory Response	0.0936474064750282	-2.36821854428195	26	1	0.05	20	5311	3574	IL7
WP3845	Canonical  and Non-canonical Notch signaling	0.0970773122201544	-2.33224758474357	27	1	0.05	20	5311	23462	HEY1
WP2858	Ectoderm Differentiation	0.0997803350065364	-2.30478415910312	143	2	0.1	20	5311	60401,79776	EDA2R,ZFHX4
WP2884	NRF2 pathway	0.0997803350065364	-2.30478415910312	143	2	0.1	20	5311	55117,2042	SLC6A15,EPHA3
WP34	Ovarian Infertility Genes	0.1140426825357	-2.17118249245301	32	1	0.05	20	5311	658	BMPR1B
WP3893	Development and heterogeneity of the ILC family	0.1140426825357	-2.17118249245301	32	1	0.05	20	5311	3574	IL7
WP2828	Bladder Cancer	0.1140426825357	-2.17118249245301	32	1	0.05	20	5311	1029	CDKN2A
WP2857	Mesodermal Commitment Pathway	0.115453458394223	-2.15888778785531	156	2	0.1	20	5311	79776,23007	ZFHX4,PLCH1
WP2636	Common Pathways Underlying Drug Addiction	0.147069211264513	-1.91685197807802	42	1	0.05	20	5311	2891	GRIA2
WP1591	Heart Development	0.159949483321119	-1.83289724284429	46	1	0.05	20	5311	23462	HEY1
WP465	Tryptophan metabolism	0.159949483321119	-1.83289724284429	46	1	0.05	20	5311	8942	KYNU
WP2848	Differentiation Pathway	0.166320115556948	-1.79384094064578	48	1	0.05	20	5311	10468	FST
WP3611	Photodynamic therapy-induced AP-1 survival signaling.	0.175790072665883	-1.73846476480287	51	1	0.05	20	5311	1029	CDKN2A
WP1533	Vitamin B12 Metabolism	0.18204650652268	-1.70349309420326	53	1	0.05	20	5311	6289	SAA2
WP2272	Pathogenic Escherichia coli infection	0.188257806316159	-1.66994294534698	55	1	0.05	20	5311	9076	CLDN1
WP560	TGF-beta Receptor Signaling	0.197490804109741	-1.62206325719464	58	1	0.05	20	5311	10468	FST
WP61	Notch Signaling Pathway	0.209646362007235	-1.56233315821216	62	1	0.05	20	5311	23462	HEY1
WP45	G1 to S cell cycle control	0.227552235173659	-1.48037546178742	68	1	0.05	20	5311	1029	CDKN2A
WP176	Folate Metabolism	0.23049882210645	-1.46750952672574	69	1	0.05	20	5311	6289	SAA2
WP2572	Primary Focal Segmental Glomerulosclerosis FSGS	0.245072286912199	-1.40620206333447	74	1	0.05	20	5311	9076	CLDN1
WP2261	Signaling Pathways in Glioblastoma	0.270646155570242	-1.30694301027291	83	1	0.05	20	5311	1029	CDKN2A
WP254	Apoptosis	0.278986312886121	-1.27659255611998	86	1	0.05	20	5311	1029	CDKN2A
WP1772	Apoptosis Modulation and Signaling	0.300786072443052	-1.20135598969699	94	1	0.05	20	5311	1029	CDKN2A
WP2064	Neural Crest Differentiation	0.321958724120721	-1.13333192761474	102	1	0.05	20	5311	7545	ZIC1
WP185	Integrin-mediated Cell Adhesion	0.324562069394715	-1.1252784841038	103	1	0.05	20	5311	827	CAPN6
WP179	Cell Cycle	0.329740299935973	-1.10944990423596	105	1	0.05	20	5311	1029	CDKN2A
WP710	DNA Damage Response (only ATM dependent)	0.352579195290985	-1.04248001447162	114	1	0.05	20	5311	1029	CDKN2A
WP2380	Brain-Derived Neurotrophic Factor (BDNF) signaling pathway	0.423486970361029	-0.859232531925244	144	1	0.05	20	5311	2891	GRIA2
WP306	Focal Adhesion	0.527402945940156	-0.63979041929896	195	1	0.05	20	5311	5228	PGF
WP2377	Integrated Pancreatic Cancer Pathway	0.531091134429284	-0.632821644539497	197	1	0.05	20	5311	10468	FST
WP3594	Circadian rythm related genes	0.549125586219429	-0.599428109134879	207	1	0.05	20	5311	55366	LGR4
WP229	Irinotecan Pathway	0.999999999985347	-1.46526936569871e-11	14	0	0	20	5311
WP2436	Dopamine metabolism	0.999999999985347	-1.46526936569871e-11	14	0	0	20	5311
WP322	Osteoblast Signaling	0.999999999985347	-1.46526936569871e-11	14	0	0	20	5311
WP3853	ERK Pathway in Huntington's Disease	0.999999999985347	-1.46526936569871e-11	14	0	0	20	5311
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	0.99999999998778	-1.22202628207089e-11	37	0	0	20	5311
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	0.99999999998778	-1.22202628207089e-11	37	0	0	20	5311
WP1471	Target Of Rapamycin (TOR) Signaling	0.99999999998778	-1.22202628207089e-11	37	0	0	20	5311
WP3529	Zinc homeostasis	0.99999999998778	-1.22202628207089e-11	37	0	0	20	5311
WP619	Type II interferon signaling (IFNG)	0.99999999998778	-1.22202628207089e-11	37	0	0	20	5311
WP428	Wnt Signaling Pathway	0.99999999998783	-1.21697844151189e-11	70	0	0	20	5311
WP2359	Parkin-Ubiquitin Proteasomal System pathway	0.99999999998783	-1.21697844151189e-11	70	0	0	20	5311
WP391	Mitochondrial Gene Expression	0.999999999988189	-1.18113187458823e-11	20	0	0	20	5311
WP1422	Sphingolipid Metabolism	0.999999999988189	-1.18113187458823e-11	20	0	0	20	5311
WP497	Urea cycle and metabolism of amino groups	0.999999999988189	-1.18113187458823e-11	20	0	0	20	5311
WP516	Hypertrophy Model	0.999999999988189	-1.18113187458823e-11	20	0	0	20	5311
WP732	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling	0.999999999988189	-1.18113187458823e-11	20	0	0	20	5311
WP1600	Nicotine Metabolism	0.999999999989033	-1.09671283429215e-11	6	0	0	20	5311
WP1981	Thyroxine (Thyroid Hormone) Production	0.999999999989033	-1.09671283429215e-11	6	0	0	20	5311
WP3891	Benzene metabolism	0.999999999989033	-1.09671283429215e-11	6	0	0	20	5311
WP694	Arylamine metabolism	0.999999999989033	-1.09671283429215e-11	6	0	0	20	5311
WP170	Nuclear Receptors	0.999999999989175	-1.08246064898314e-11	39	0	0	20	5311
WP1544	MicroRNAs in cardiomyocyte hypertrophy	0.999999999990301	-9.69938309332259e-12	102	0	0	20	5311
WP2889	Oxytocin signaling	0.999999999990411	-9.58921026892775e-12	4	0	0	20	5311
WP2491	Diclofenac Metabolic Pathway	0.999999999990411	-9.58921026892775e-12	4	0	0	20	5311
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	0.999999999990411	-9.58921026892775e-12	4	0	0	20	5311
WP1133	Androgen receptor signaling pathway	0.999999999990411	-9.58921026892775e-12	4	0	0	20	5311
WP897	Androgen receptor signaling pathway	0.999999999990411	-9.58921026892775e-12	4	0	0	20	5311
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	0.999999999990411	-9.58921026892775e-12	4	0	0	20	5311
WP733	Serotonin Receptor 2 and STAT3 Signaling	0.999999999990411	-9.58921026892775e-12	4	0	0	20	5311
WP2253	Pilocytic astrocytoma	0.999999999990411	-9.58921026892775e-12	4	0	0	20	5311
WP690	Polyol Pathway	0.999999999990411	-9.58921026892775e-12	4	0	0	20	5311
WP521	Amino acid conjugation of benzoic acid	0.999999999990411	-9.58921026892775e-12	4	0	0	20	5311
WP3633	Caffeine and Theobromine metabolism	0.999999999990411	-9.58921026892775e-12	4	0	0	20	5311
WP1603	Nicotine Activity on Chromaffin Cells	0.999999999990411	-9.58921026892775e-12	4	0	0	20	5311
WP2533	Glycerophospholipid Biosynthetic Pathway	0.999999999990469	-9.5315400805138e-12	21	0	0	20	5311
WP691	Tamoxifen metabolism	0.999999999990469	-9.5315400805138e-12	21	0	0	20	5311
WP2507	Nanomaterial induced apoptosis	0.999999999990469	-9.5315400805138e-12	21	0	0	20	5311
WP1602	Nicotine Activity on Dopaminergic Neurons	0.999999999990469	-9.5315400805138e-12	21	0	0	20	5311
WP3670	Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway	0.999999999990469	-9.5315400805138e-12	21	0	0	20	5311
WP364	IL-6 signaling pathway	0.999999999990891	-9.10872528615751e-12	43	0	0	20	5311
WP2911	miRNA targets in ECM and membrane receptors	0.999999999990891	-9.10872528615751e-12	43	0	0	20	5311
WP51	Regulation of Actin Cytoskeleton	0.999999999991578	-8.42187608424371e-12	149	0	0	20	5311
WP558	Complement and Coagulation Cascades	0.999999999991697	-8.30304947947962e-12	60	0	0	20	5311
WP304	Kit receptor signaling pathway	0.999999999991697	-8.30304947947962e-12	60	0	0	20	5311
WP3527	Preimplantation Embryo	0.999999999991697	-8.30304947947962e-12	60	0	0	20	5311
WP2035	Follicle Stimulating Hormone (FSH) signaling pathway	0.999999999991703	-8.29686193716428e-12	27	0	0	20	5311
WP3585	Cytosine methylation	0.99999999999179	-8.20951642240651e-12	9	0	0	20	5311
WP3674	Tgif disruption of Shh signaling	0.99999999999179	-8.20951642240651e-12	9	0	0	20	5311
WP3300	Dual hijack model of Vif in HIV infection	0.99999999999179	-8.20951642240651e-12	9	0	0	20	5311
WP561	Heme Biosynthesis	0.99999999999179	-8.20951642240651e-12	9	0	0	20	5311
WP3297	EV release from cardiac cells and their functional effects	0.99999999999179	-8.20951642240651e-12	9	0	0	20	5311
WP3875	ATR Signaling	0.99999999999179	-8.20951642240651e-12	9	0	0	20	5311
WP288	NLR Proteins	0.99999999999179	-8.20951642240651e-12	9	0	0	20	5311
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	0.99999999999179	-8.20951642240651e-12	9	0	0	20	5311
WP696	Benzo(a)pyrene metabolism	0.99999999999179	-8.20951642240651e-12	9	0	0	20	5311
WP531	Mismatch repair	0.99999999999179	-8.20951642240651e-12	9	0	0	20	5311
WP474	Endochondral Ossification	0.99999999999193	-8.07020196247939e-12	65	0	0	20	5311
WP411	mRNA Processing	0.999999999992238	-7.76172294225242e-12	132	0	0	20	5311
WP3915	Angiopoietin Like Protein 8 Regulatory Pathway	0.999999999992238	-7.76172294225242e-12	132	0	0	20	5311
WP1403	AMP-activated Protein Kinase (AMPK) Signaling	0.999999999992331	-7.66905818171355e-12	68	0	0	20	5311
WP3680	Association Between Physico-Chemical Features and Toxicity Associated Pathways	0.999999999992331	-7.66905818171355e-12	68	0	0	20	5311
WP2032	Human Thyroid Stimulating Hormone (TSH) signaling pathway	0.999999999992331	-7.66905818171355e-12	68	0	0	20	5311
WP3303	Rac1/Pak1/p38/MMP-2 pathway	0.999999999992331	-7.66905818171355e-12	68	0	0	20	5311
WP2113	Type III interferon signaling	0.999999999992555	-7.44554340278239e-12	10	0	0	20	5311
WP496	Steroid Biosynthesis	0.999999999992555	-7.44554340278239e-12	10	0	0	20	5311
WP2333	Trans-sulfuration pathway	0.999999999992555	-7.44554340278239e-12	10	0	0	20	5311
WP3601	Composition of Lipid Particles	0.999999999992555	-7.44554340278239e-12	10	0	0	20	5311
WP1531	Vitamin D Metabolism	0.999999999992555	-7.44554340278239e-12	10	0	0	20	5311
WP704	Methylation Pathways	0.999999999992555	-7.44554340278239e-12	10	0	0	20	5311
WP2874	Liver X Receptor Pathway	0.999999999992555	-7.44554340278239e-12	10	0	0	20	5311
WP3656	Interleukin-1 Induced Activation of NF-kappa-B	0.999999999992555	-7.44554340278239e-12	10	0	0	20	5311
WP3851	TLR4 Signaling and Tolerance	0.99999999999284	-7.16026037019053e-12	30	0	0	20	5311
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	0.99999999999284	-7.16026037019053e-12	30	0	0	20	5311
WP98	Prostaglandin Synthesis and Regulation	0.99999999999284	-7.16026037019053e-12	30	0	0	20	5311
WP2855	Dopaminergic Neurogenesis	0.99999999999284	-7.16026037019053e-12	30	0	0	20	5311
WP2870	Extracellular vesicle-mediated signaling in recipient cells	0.99999999999284	-7.16026037019053e-12	30	0	0	20	5311
WP129	Matrix Metalloproteinases	0.99999999999284	-7.16026037019053e-12	30	0	0	20	5311
WP241	One Carbon Metabolism	0.99999999999284	-7.16026037019053e-12	30	0	0	20	5311
WP69	T-Cell antigen Receptor (TCR)  Signaling Pathway	0.999999999992844	-7.15594525581436e-12	91	0	0	20	5311
WP3925	Amino Acid metabolism	0.999999999992844	-7.15594525581436e-12	91	0	0	20	5311
WP3286	Copper homeostasis	0.999999999992921	-7.07890326534586e-12	54	0	0	20	5311
WP623	Oxidative phosphorylation	0.999999999992921	-7.07890326534586e-12	54	0	0	20	5311
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	0.999999999992921	-7.07890326534586e-12	54	0	0	20	5311
WP673	ErbB Signaling Pathway	0.999999999992921	-7.07890326534586e-12	54	0	0	20	5311
WP3651	Pathways Affected in Adenoid Cystic Carcinoma	0.999999999993252	-6.74805468108942e-12	66	0	0	20	5311
WP2324	AGE/RAGE pathway	0.999999999993252	-6.74805468108942e-12	66	0	0	20	5311
WP183	Proteasome Degradation	0.999999999993252	-6.74805468108942e-12	66	0	0	20	5311
WP2374	Oncostatin M Signaling Pathway	0.999999999993252	-6.74805468108942e-12	66	0	0	20	5311
WP289	Myometrial Relaxation and Contraction Pathways	0.999999999993301	-6.69926317512425e-12	158	0	0	20	5311
WP3859	TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition	0.99999999999337	-6.62985997809401e-12	18	0	0	20	5311
WP3664	Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds	0.99999999999337	-6.62985997809401e-12	18	0	0	20	5311
WP692	Sulfation Biotransformation Reaction	0.99999999999337	-6.62985997809401e-12	18	0	0	20	5311
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	0.99999999999337	-6.62985997809401e-12	18	0	0	20	5311
WP3413	NOTCH1 regulation of human endothelial cell calcification	0.99999999999337	-6.62985997809401e-12	18	0	0	20	5311
WP299	Nuclear Receptors in Lipid Metabolism and Toxicity	0.99999999999354	-6.45966838283578e-12	35	0	0	20	5311
WP3617	Photodynamic therapy-induced NF-kB survival signaling	0.99999999999354	-6.45966838283578e-12	35	0	0	20	5311
WP244	Alpha 6 Beta 4 signaling pathway	0.99999999999354	-6.45966838283578e-12	35	0	0	20	5311
WP2583	T-Cell Receptor and Co-stimulatory Signaling	0.999999999993651	-6.34880004540153e-12	29	0	0	20	5311
WP422	MAPK Cascade	0.999999999993651	-6.34880004540153e-12	29	0	0	20	5311
WP2643	Nanoparticle-mediated activation of receptor signaling	0.999999999993651	-6.34880004540153e-12	29	0	0	20	5311
WP3613	Photodynamic therapy-induced unfolded protein response	0.999999999993651	-6.34880004540153e-12	29	0	0	20	5311
WP410	Diurnally Regulated Genes with Circadian Orthologs	0.99999999999369	-6.31037980361791e-12	49	0	0	20	5311
WP286	IL-3 Signaling Pathway	0.99999999999369	-6.31037980361791e-12	49	0	0	20	5311
WP534	Glycolysis and Gluconeogenesis	0.99999999999369	-6.31037980361791e-12	49	0	0	20	5311
WP231	TNF alpha Signaling Pathway	0.999999999993811	-6.18921697282629e-12	94	0	0	20	5311
WP2873	Aryl Hydrocarbon Receptor Pathway	0.999999999994121	-5.87944986249252e-12	48	0	0	20	5311
WP2849	Hematopoietic Stem Cell Differentiation	0.999999999994121	-5.87944986249252e-12	48	0	0	20	5311
WP2586	Aryl Hydrocarbon Receptor	0.999999999994121	-5.87944986249252e-12	48	0	0	20	5311
WP28	Selenium Metabolism and Selenoproteins	0.999999999994214	-5.7861283590599e-12	46	0	0	20	5311
WP268	Notch Signaling Pathway	0.999999999994214	-5.7861283590599e-12	46	0	0	20	5311
WP1971	Integrated Cancer Pathway	0.999999999994214	-5.7861283590599e-12	46	0	0	20	5311
WP3878	ATM Signaling Network in Development and Disease	0.999999999994214	-5.7861283590599e-12	46	0	0	20	5311
WP2854	Gene regulatory network modelling somitogenesis	0.999999999994413	-5.58655265909703e-12	11	0	0	20	5311
WP80	Nucleotide GPCRs	0.999999999994413	-5.58655265909703e-12	11	0	0	20	5311
WP2513	Nanoparticle triggered regulated necrosis	0.999999999994413	-5.58655265909703e-12	11	0	0	20	5311
WP1455	Serotonin Transporter Activity	0.999999999994413	-5.58655265909703e-12	11	0	0	20	5311
WP3630	NAD metabolism, sirtuins and aging	0.999999999994413	-5.58655265909703e-12	11	0	0	20	5311
WP23	B Cell Receptor Signaling Pathway	0.99999999999451	-5.49023348206482e-12	98	0	0	20	5311
WP455	GPCRs, Class A Rhodopsin-like	0.999999999994533	-5.46684806554038e-12	259	0	0	20	5311
WP2249	Metastatic brain tumor	0.999999999994556	-5.44363017612329e-12	28	0	0	20	5311
WP2361	Gastric Cancer Network 1	0.999999999994556	-5.44363017612329e-12	28	0	0	20	5311
WP138	Androgen receptor signaling pathway	0.999999999994707	-5.29290126651304e-12	90	0	0	20	5311
WP477	Cytoplasmic Ribosomal Proteins	0.999999999994707	-5.29290126651304e-12	90	0	0	20	5311
WP399	Wnt Signaling Pathway and Pluripotency	0.999999999994715	-5.28544369312676e-12	106	0	0	20	5311
WP1984	Integrated Breast Cancer Pathway	0.999999999995047	-4.95316854247002e-12	154	0	0	20	5311
WP707	DNA Damage Response	0.999999999995076	-4.92389903690027e-12	69	0	0	20	5311
WP2369	Histone Modifications	0.999999999995076	-4.92389903690027e-12	69	0	0	20	5311
WP1528	Physiological and Pathological Hypertrophy  of the Heart	0.999999999995529	-4.4707887749162e-12	25	0	0	20	5311
WP3668	Hypothesized Pathways in Pathogenesis of Cardiovascular Disease	0.999999999995529	-4.4707887749162e-12	25	0	0	20	5311
WP2865	IL1 and megakaryocytes in obesity	0.999999999995529	-4.4707887749162e-12	25	0	0	20	5311
WP2371	Parkinsons Disease Pathway	0.999999999995533	-4.46665772095707e-12	83	0	0	20	5311
WP1438	Influenza A virus infection	0.999999999995646	-4.35424504612036e-12	2	0	0	20	5311
WP2816	Felbamate Metabolism	0.999999999995646	-4.35424504612036e-12	2	0	0	20	5311
WP2866	mir34a and TGIF2 in osteoclastogenesis	0.999999999995646	-4.35424504612036e-12	2	0	0	20	5311
WP2366	Butyrate-induced histone acetylation	0.999999999995646	-4.35424504612036e-12	2	0	0	20	5311
WP1311	Folic Acid Network	0.999999999995646	-4.35424504612036e-12	2	0	0	20	5311
WP2943	Hypoxia-mediated EMT and Stemness	0.999999999995646	-4.35424504612036e-12	2	0	0	20	5311
WP1273	Folic Acid Network	0.999999999995646	-4.35424504612036e-12	2	0	0	20	5311
WP2646	Lidocaine metabolism	0.999999999995646	-4.35424504612036e-12	2	0	0	20	5311
WP2901	Gonadotropin-releasing hormone (GnRH) signaling	0.999999999995646	-4.35424504612036e-12	2	0	0	20	5311
WP2355	Corticotropin-releasing hormone signaling pathway	0.999999999995844	-4.15580925833441e-12	93	0	0	20	5311
WP1530	miRNA Regulation of DNA Damage Response	0.999999999995844	-4.15580925833441e-12	93	0	0	20	5311
WP1982	Sterol Regulatory Element-Binding Proteins (SREBP) signalling	0.999999999996047	-3.95334796506201e-12	73	0	0	20	5311
WP712	Estrogen signaling pathway	0.999999999996265	-3.73498970834667e-12	23	0	0	20	5311
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	0.999999999996265	-3.73498970834667e-12	23	0	0	20	5311
WP2525	Trans-sulfuration and one carbon metabolism	0.999999999996352	-3.64798609862859e-12	32	0	0	20	5311
WP2875	Constitutive Androstane Receptor Pathway	0.999999999996352	-3.64798609862859e-12	32	0	0	20	5311
WP3858	Toll-like Receptor Signaling	0.999999999996352	-3.64798609862859e-12	32	0	0	20	5311
WP727	Monoamine Transport	0.999999999996352	-3.64798609862859e-12	32	0	0	20	5311
WP186	Homologous recombination	0.999999999996807	-3.19305286560835e-12	13	0	0	20	5311
WP3892	Development of pulmonary dendritic cells and macrophage subsets	0.999999999996807	-3.19305286560835e-12	13	0	0	20	5311
WP3871	Valproic acid pathway	0.999999999996807	-3.19305286560835e-12	13	0	0	20	5311
WP3876	BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation	0.999999999996807	-3.19305286560835e-12	13	0	0	20	5311
WP1423	Ganglio Sphingolipid Metabolism	0.999999999996807	-3.19305286560835e-12	13	0	0	20	5311
WP3679	Cell-type Dependent Selectivity of CCK2R Signaling	0.999999999996807	-3.19305286560835e-12	13	0	0	20	5311
WP2881	Estrogen Receptor Pathway	0.999999999996807	-3.19305286560835e-12	13	0	0	20	5311
WP1434	Osteopontin Signaling	0.999999999996807	-3.19305286560835e-12	13	0	0	20	5311
WP1991	SRF and miRs in Smooth Muscle Differentiation and Proliferation	0.999999999996807	-3.19305286560835e-12	13	0	0	20	5311
WP236	Adipogenesis	0.999999999996834	-3.16652183480764e-12	131	0	0	20	5311
WP466	DNA Replication	0.999999999996954	-3.04567718119034e-12	42	0	0	20	5311
WP49	IL-2 Signaling Pathway	0.999999999996954	-3.04567718119034e-12	42	0	0	20	5311
WP2036	TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway	0.999999999996954	-3.04567718119034e-12	42	0	0	20	5311
WP405	Eukaryotic Transcription Initiation	0.999999999996954	-3.04567718119034e-12	42	0	0	20	5311
WP536	Calcium Regulation in the Cardiac Cell	0.999999999997027	-2.97267895099618e-12	151	0	0	20	5311
WP3865	RIG-I-like Receptor Signaling	0.99999999999728	-2.71998400098563e-12	61	0	0	20	5311
WP2795	Cardiac Hypertrophic Response	0.999999999997692	-2.30791567082489e-12	57	0	0	20	5311
WP195	IL-1 signaling pathway	0.999999999997692	-2.30791567082489e-12	57	0	0	20	5311
WP188	Focal Adhesion	0.999999999997747	-2.25299119638311e-12	1	0	0	20	5311
WP2536	Colchicine Metabolic Pathway	0.999999999997747	-2.25299119638311e-12	1	0	0	20	5311
WP661	Glucose Homeostasis	0.999999999997747	-2.25299119638311e-12	1	0	0	20	5311
WP3191	TSLP Signaling Pathway	0.999999999997747	-2.25299119638311e-12	1	0	0	20	5311
WP3627	Gut-Liver Indole Metabolism	0.999999999997747	-2.25299119638311e-12	1	0	0	20	5311
WP2190	One carbon donor	0.999999999997747	-2.25299119638311e-12	1	0	0	20	5311
WP108	Selenium metabolism/Selenoproteins	0.999999999997747	-2.25299119638311e-12	1	0	0	20	5311
WP1	Statin Pathway	0.999999999997747	-2.25299119638311e-12	1	0	0	20	5311
WP107	Translation Factors	0.999999999997878	-2.12219859680592e-12	53	0	0	20	5311
WP363	Wnt Signaling Pathway Netpath	0.999999999997878	-2.12219859680592e-12	53	0	0	20	5311
WP2406	Cardiac Progenitor Differentiation	0.999999999997878	-2.12219859680592e-12	53	0	0	20	5311
WP272	Blood Clotting Cascade	0.999999999997893	-2.10656481107856e-12	22	0	0	20	5311
WP3657	Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex	0.999999999997893	-2.10656481107856e-12	22	0	0	20	5311
WP3645	NAD+ biosynthetic pathways	0.999999999997893	-2.10656481107856e-12	22	0	0	20	5311
WP3872	Regulation of Apoptosis by Parathyroid Hormone-related Protein	0.999999999997893	-2.10656481107856e-12	22	0	0	20	5311
WP545	Complement Activation	0.999999999997893	-2.10656481107856e-12	22	0	0	20	5311
WP1424	Globo Sphingolipid Metabolism	0.999999999997893	-2.10656481107856e-12	22	0	0	20	5311
WP1584	Type II diabetes mellitus	0.999999999997893	-2.10656481107856e-12	22	0	0	20	5311
WP357	Fatty Acid Biosynthesis	0.999999999997893	-2.10656481107856e-12	22	0	0	20	5311
WP100	Glutathione metabolism	0.999999999997893	-2.10656481107856e-12	22	0	0	20	5311
WP3599	Transcription factor regulation in adipogenesis	0.999999999997893	-2.10656481107856e-12	22	0	0	20	5311
WP167	Eicosanoid Synthesis	0.999999999997893	-2.10656481107856e-12	22	0	0	20	5311
WP706	Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways	0.999999999997901	-2.09923430778466e-12	162	0	0	20	5311
WP437	EGF/EGFR Signaling Pathway	0.999999999997901	-2.09923430778466e-12	162	0	0	20	5311
WP1539	Angiogenesis	0.999999999998027	-1.97325665912493e-12	24	0	0	20	5311
WP2509	Nanoparticle triggered autophagic cell death	0.999999999998027	-1.97325665912493e-12	24	0	0	20	5311
WP334	GPCRs, Class B Secretin-like	0.999999999998027	-1.97325665912493e-12	24	0	0	20	5311
WP262	EBV LMP1 signaling	0.999999999998027	-1.97325665912493e-12	24	0	0	20	5311
WP3658	Wnt/beta-catenin Signaling Pathway in Leukemia	0.999999999998027	-1.97325665912493e-12	24	0	0	20	5311
WP111	Electron Transport Chain	0.99999999999805	-1.94955809787948e-12	92	0	0	20	5311
WP314	Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation	0.999999999998051	-1.94905188202896e-12	44	0	0	20	5311
WP2332	Interleukin-11 Signaling Pathway	0.999999999998051	-1.94905188202896e-12	44	0	0	20	5311
WP716	Vitamin A and Carotenoid Metabolism	0.999999999998051	-1.94905188202896e-12	44	0	0	20	5311
WP2431	Spinal Cord Injury	0.999999999998101	-1.89903621194725e-12	119	0	0	20	5311
WP2018	RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway	0.999999999998121	-1.87905779529423e-12	55	0	0	20	5311
WP395	IL-4 Signaling Pathway	0.999999999998121	-1.87905779529423e-12	55	0	0	20	5311
WP585	Interferon type I signaling pathways	0.999999999998121	-1.87905779529423e-12	55	0	0	20	5311
WP2059	Alzheimers Disease	0.99999999999818	-1.82046684291908e-12	148	0	0	20	5311
WP127	IL-5 Signaling Pathway	0.999999999998238	-1.76204535414139e-12	40	0	0	20	5311
WP2516	ATM Signaling Pathway	0.999999999998238	-1.76204535414139e-12	40	0	0	20	5311
WP524	G13 Signaling Pathway	0.999999999998238	-1.76204535414139e-12	40	0	0	20	5311
WP1433	Nucleotide-binding Oligomerization Domain (NOD) pathway	0.999999999998548	-1.45190625194752e-12	41	0	0	20	5311
WP2203	Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway	0.999999999999043	-9.56659478356932e-13	47	0	0	20	5311
WP2034	Leptin signaling pathway	0.999999999999428	-5.71718348864041e-13	76	0	0	20	5311
WP2118	Arrhythmogenic Right Ventricular Cardiomyopathy	0.999999999999428	-5.71718348864041e-13	76	0	0	20	5311
WP2037	Prolactin Signaling Pathway	0.999999999999428	-5.71718348864041e-13	76	0	0	20	5311
WP24	Peptide GPCRs	1.00000000000007	7.12197458032739e-14	74	0	0	20	5311
WP3298	Melatonin metabolism and effects	1.0000000000006	5.95733497216164e-13	36	0	0	20	5311
WP500	Glycogen Metabolism	1.0000000000006	5.95733497216164e-13	36	0	0	20	5311
WP2012	miRs in Muscle Cell Differentiation	1.0000000000006	5.95733497216164e-13	36	0	0	20	5311
WP408	Oxidative Stress	1.00000000000061	6.06314738386347e-13	31	0	0	20	5311
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	1.00000000000061	6.06314738386347e-13	31	0	0	20	5311
WP2112	IL17 signaling pathway	1.00000000000061	6.06314738386347e-13	31	0	0	20	5311
WP2846	Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation	1.00000000000061	6.14654191640038e-13	3	0	0	20	5311
WP3408	Evolocumab Mechanism	1.00000000000061	6.14654191640038e-13	3	0	0	20	5311
WP3596	miR-517 relationship with ARCN1 and USP1	1.00000000000087	8.69876000949737e-13	5	0	0	20	5311
WP2597	Secretion of Hydrochloric Acid in Parietal Cells	1.00000000000087	8.69876000949737e-13	5	0	0	20	5311
WP311	Synthesis and Degradation of Ketone Bodies	1.00000000000087	8.69876000949737e-13	5	0	0	20	5311
WP688	Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)	1.00000000000087	8.69876000949737e-13	5	0	0	20	5311
WP2542	Sulindac Metabolic Pathway	1.00000000000087	8.69876000949737e-13	5	0	0	20	5311
WP2868	TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer	1.00000000000087	8.69876000949737e-13	5	0	0	20	5311
WP197	Cholesterol Biosynthesis	1.00000000000093	9.25139296330083e-13	15	0	0	20	5311
WP206	Fatty Acid Omega Oxidation	1.00000000000093	9.25139296330083e-13	15	0	0	20	5311
WP2435	Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis	1.00000000000093	9.25139296330083e-13	15	0	0	20	5311
WP3	Transcriptional activation by NRF2	1.00000000000093	9.25139296330083e-13	15	0	0	20	5311
WP58	Monoamine GPCRs	1.00000000000131	1.30961207618764e-12	33	0	0	20	5311
WP2197	Endothelin Pathways	1.00000000000131	1.30961207618764e-12	33	0	0	20	5311
WP2363	Gastric Cancer Network 2	1.00000000000131	1.30961207618764e-12	33	0	0	20	5311
WP453	Inflammatory Response Pathway	1.00000000000131	1.30961207618764e-12	33	0	0	20	5311
WP430	Statin Pathway	1.00000000000131	1.30961207618764e-12	33	0	0	20	5311
WP3676	BDNF-TrkB Signaling	1.00000000000131	1.30961207618764e-12	33	0	0	20	5311
WP3644	NAD+ metabolism	1.00000000000132	1.32061738079451e-12	16	0	0	20	5311
WP550	Biogenic Amine Synthesis	1.00000000000132	1.32061738079451e-12	16	0	0	20	5311
WP501	GPCRs, Class C Metabotropic glutamate, pheromone	1.00000000000132	1.32061738079451e-12	16	0	0	20	5311
WP2291	Deregulation of Rab and Rab Effector Genes in Bladder Cancer	1.00000000000132	1.32061738079451e-12	16	0	0	20	5311
WP53	ID signaling pathway	1.00000000000132	1.32061738079451e-12	16	0	0	20	5311
WP12	Osteoclast Signaling	1.00000000000132	1.32061738079451e-12	16	0	0	20	5311
WP2453	TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)	1.00000000000132	1.32061738079451e-12	16	0	0	20	5311
WP1946	Cori Cycle	1.00000000000132	1.32061738079451e-12	16	0	0	20	5311
WP47	Hedgehog Signaling Pathway	1.00000000000132	1.32061738079451e-12	16	0	0	20	5311
WP481	Insulin Signaling	1.00000000000146	1.46386519742626e-12	161	0	0	20	5311
WP702	Metapathway biotransformation	1.00000000000183	1.82557052029162e-12	177	0	0	20	5311
WP117	GPCRs, Other	1.00000000000184	1.84345560301233e-12	95	0	0	20	5311
WP35	G Protein Signaling Pathways	1.00000000000184	1.84345560301233e-12	95	0	0	20	5311
WP2328	Allograft Rejection	1.0000000000019	1.89831307388576e-12	80	0	0	20	5311
WP382	MAPK Signaling Pathway	1.00000000000249	2.48652932472193e-12	170	0	0	20	5311
WP313	Signaling of Hepatocyte Growth Factor Receptor	1.00000000000254	2.54243218947245e-12	34	0	0	20	5311
WP1601	Fluoropyrimidine Activity	1.00000000000254	2.54243218947245e-12	34	0	0	20	5311
WP143	Fatty Acid Beta Oxidation	1.00000000000254	2.54243218947245e-12	34	0	0	20	5311
WP400	p38 MAPK Signaling Pathway	1.00000000000254	2.54243218947245e-12	34	0	0	20	5311
WP366	TGF-beta Signaling Pathway	1.00000000000304	3.03818353502139e-12	133	0	0	20	5311
WP2267	Synaptic Vesicle Pathway	1.00000000000333	3.33151065198127e-12	52	0	0	20	5311
WP2446	Retinoblastoma (RB) in Cancer	1.00000000000336	3.35556715399736e-12	88	0	0	20	5311
WP26	Signal Transduction of S1P Receptor	1.00000000000346	3.46156132065647e-12	26	0	0	20	5311
WP581	EPO Receptor Signaling	1.00000000000346	3.46156132065647e-12	26	0	0	20	5311
WP325	Triacylglyceride Synthesis	1.00000000000346	3.46156132065647e-12	26	0	0	20	5311
WP698	Glucuronidation	1.00000000000346	3.46156132065647e-12	26	0	0	20	5311
WP2878	PPAR Alpha Pathway	1.00000000000346	3.46156132065647e-12	26	0	0	20	5311
WP75	Toll-like Receptor Signaling Pathway	1.00000000000352	3.51966343919686e-12	103	0	0	20	5311
WP2805	RNA interference	1.00000000000456	4.56299918433305e-12	7	0	0	20	5311
WP3924	Hfe effect on hepcidin production	1.00000000000456	4.56299918433305e-12	7	0	0	20	5311
WP438	Non-homologous end joining	1.00000000000456	4.56299918433305e-12	7	0	0	20	5311
WP678	Arachidonate Epoxygenase / Epoxide Hydrolase	1.00000000000456	4.56299918433305e-12	7	0	0	20	5311
WP1310	Selenium Micronutrient Network	1.00000000000456	4.56299918433305e-12	7	0	0	20	5311
WP2596	Gastric acid production	1.00000000000456	4.56299918433305e-12	7	0	0	20	5311
WP1995	Effects of Nitric Oxide	1.00000000000456	4.56299918433305e-12	7	0	0	20	5311
WP528	Acetylcholine Synthesis	1.00000000000456	4.56299918433305e-12	7	0	0	20	5311
WP1272	Selenium Micronutrient Network	1.00000000000456	4.56299918433305e-12	7	0	0	20	5311
WP3595	mir-124 predicted interactions with cell cycle and differentiation	1.00000000000456	4.56299918433305e-12	7	0	0	20	5311
WP134	Pentose Phosphate Pathway	1.00000000000456	4.56299918433305e-12	7	0	0	20	5311
WP699	Aflatoxin B1 metabolism	1.00000000000456	4.56299918433305e-12	7	0	0	20	5311
WP3646	Hepatitis C and Hepatocellular Carcinoma	1.00000000000458	4.57907704769643e-12	51	0	0	20	5311
WP1449	Regulation of toll-like receptor signaling pathway	1.00000000000466	4.66449611022105e-12	145	0	0	20	5311
WP43	Oxidation by Cytochrome P450	1.00000000000481	4.81381690952185e-12	63	0	0	20	5311
WP3624	Lung fibrosis	1.00000000000481	4.81381690952185e-12	63	0	0	20	5311
WP3863	T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection	1.00000000000517	5.16935810093746e-12	62	0	0	20	5311
WP3584	MECP2 and Associated Rett Syndrome	1.00000000000517	5.16935810093746e-12	62	0	0	20	5311
WP2290	RalA downstream regulated genes	1.00000000000531	5.30880606537547e-12	12	0	0	20	5311
WP106	Alanine and aspartate metabolism	1.00000000000531	5.30880606537547e-12	12	0	0	20	5311
WP1559	TFs Regulate miRNAs related to cardiac hypertrophy	1.00000000000531	5.30880606537547e-12	12	0	0	20	5311
WP3849	MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ	1.00000000000531	5.30880606537547e-12	12	0	0	20	5311
WP3672	LncRNA-mediated mechanisms of therapeutic resistance	1.00000000000531	5.30880606537547e-12	12	0	0	20	5311
WP2007	Iron metabolism in placenta	1.00000000000531	5.30880606537547e-12	12	0	0	20	5311
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	1.00000000000531	5.30880606537547e-12	12	0	0	20	5311
WP2637	Structural Pathway of Interleukin 1 (IL-1)	1.00000000000542	5.4198053760045e-12	50	0	0	20	5311
WP1545	miRNAs involved in DNA damage response	1.00000000000542	5.4198053760045e-12	50	0	0	20	5311
WP3635	Insulin signalling in human adipocytes (diabetic condition)	1.00000000000576	5.76281995546772e-12	8	0	0	20	5311
WP2338	miRNA Biogenesis	1.00000000000576	5.76281995546772e-12	8	0	0	20	5311
WP3634	Insulin signalling in human adipocytes (normal condition)	1.00000000000576	5.76281995546772e-12	8	0	0	20	5311
WP1589	Folate-Alcohol and Cancer Pathway	1.00000000000576	5.76281995546772e-12	8	0	0	20	5311
WP2276	Glial Cell Differentiation	1.00000000000576	5.76281995546772e-12	8	0	0	20	5311
WP3655	Hypothetical Craniofacial Development Pathway	1.00000000000576	5.76281995546772e-12	8	0	0	20	5311
WP3407	FTO Obesity Variant Mechanism	1.00000000000576	5.76281995546772e-12	8	0	0	20	5311
WP237	Glucocorticoid &amp; Mineralcorticoid Metabolism	1.00000000000576	5.76281995546772e-12	8	0	0	20	5311
WP136	Phase I biotransformations, non P450	1.00000000000576	5.76281995546772e-12	8	0	0	20	5311
WP1604	Codeine and Morphine Metabolism	1.00000000000576	5.76281995546772e-12	8	0	0	20	5311
WP2029	Cell Differentiation - Index	1.00000000000708	7.08481067007324e-12	38	0	0	20	5311
WP383	Striated Muscle Contraction	1.00000000000708	7.08481067007324e-12	38	0	0	20	5311
WP2526	PDGF Pathway	1.00000000000708	7.08481067007324e-12	38	0	0	20	5311
WP2447	Amyotrophic lateral sclerosis (ALS)	1.00000000000708	7.08481067007324e-12	38	0	0	20	5311
WP697	Estrogen metabolism	1.00000000000735	7.35467443683953e-12	19	0	0	20	5311
WP404	Nucleotide Metabolism	1.00000000000735	7.35467443683953e-12	19	0	0	20	5311
WP3287	Overview of nanoparticle effects	1.00000000000735	7.35467443683953e-12	19	0	0	20	5311
WP734	Serotonin Receptor 4/6/7 and NR3C Signaling	1.00000000000735	7.35467443683953e-12	19	0	0	20	5311
WP384	Apoptosis Modulation by HSP70	1.00000000000735	7.35467443683953e-12	19	0	0	20	5311
WP2879	Farnesoid X Receptor  Pathway	1.00000000000735	7.35467443683953e-12	19	0	0	20	5311
WP22	IL-9 Signaling Pathway	1.00000000000735	7.35467443683953e-12	19	0	0	20	5311
WP3877	Simplified Depiction of MYD88 Distinct Input-Output Pathway	1.00000000000735	7.35467443683953e-12	19	0	0	20	5311
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	1.00000000000735	7.35467443683953e-12	19	0	0	20	5311
WP1992	TarBasePathway	1.00000000000735	7.35467443683953e-12	19	0	0	20	5311
WP247	Small Ligand GPCRs	1.00000000000735	7.35467443683953e-12	19	0	0	20	5311
WP78	TCA Cycle	1.00000000000924	9.23861445734235e-12	17	0	0	20	5311
WP554	ACE Inhibitor Pathway	1.00000000000924	9.23861445734235e-12	17	0	0	20	5311
WP3874	Canonical and Non-Canonical TGF-B signaling	1.00000000000924	9.23861445734235e-12	17	0	0	20	5311
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	1.00000000000924	9.23861445734235e-12	17	0	0	20	5311
WP368	Mitochondrial LC-Fatty Acid Beta-Oxidation	1.00000000000924	9.23861445734235e-12	17	0	0	20	5311
WP3678	Amplification and Expansion of Oncogenic Pathways as Metastatic Traits	1.00000000000924	9.23861445734235e-12	17	0	0	20	5311
WP2289	Drug Induction of Bile Acid Pathway	1.00000000000924	9.23861445734235e-12	17	0	0	20	5311
